New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: A preliminary SAR profile

Purinergic Signalling

Volumn 3, Issue 4, 2007, Pages 339-346

  Lambertucci, Catia ^a   Cristalli, Gloria ^a   Dal Ben, Diego ^a   Kachare, Dhuldeo D ^a   Bolcato, Chiara ^b   Klotz, Karl Norbert ^c   Spalluto, Giampiero ^b   Volpini, Rosaria ^a,d  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Dipartimento di Scienze Chimiche   (Italy)

Author keywords

Adenine derivatives; Adenosine receptor antagonists; Adenosine receptor ligands; Adenosine receptors; Gprotein coupled receptors

Indexed keywords

EID: 36248962619     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-007-9068-9     Document Type: Article

References (34)

1. Cristalli G, Volpini R (eds) (2003) Adenosine receptors: Medicinal chemistry, pharmacology and therapeutic applications. Curr Top Med Chem 3:355-469
2. Robeva AS, Woodard RL, Ji XD, Gao Z, Bhattacharya S, Taylor HE, Rosin DL, Linden J (1996) Molecular characterization of recombinant human adenosine receptors. Drug Dev Res 39:243-252
3. Fredholm BB, IJzerman AP, Klotz K-N, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-533
4. Jacobson MJ (2002) Adenosine receptor agonists. Expert Opin Ther Pat 12:489-501
5. 2B receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96:1979-1986
6. Marquardt DL, Walker LL, Heinemann S (1994) Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 152:4508-4515
7. Boyle DL, Sajjadi FG, Firestein GS (1996) Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum 39:923-930
8. 2B receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem 66:1426-1431
9. 2B receptors. Hypertension 27:786-793
10. 2B receptors. Pharmacol Rev 49:381-402
11. 2B receptors as therapeutic targets. Drug Dev Res 45:198-206
12. 2B receptors. Biochem Pharmacol 55:627-633
13. 2B receptor ligands. Med Res Rev 26:667-698
14. 2B adenosine receptors. J Med Chem 43:1165-1172
15. 2B adenosine receptor antagonists. J Med Chem 49:3682-3692
16. 2B adenosine receptor subtypes: a molecular modeling investigation. J Med Chem 46:4287-4296
17. Vidal B, Nueda A, Esteve C, Domenech T, Benito S, Renoso RF, Pont M, Calbet M, Lopez R, Cadavid MI, Loza MI, Cardenas A, Godessart N, Beleta J, Warzelow G, Ryder H (2007) Discovery and characterization of 4′-(2-furyl)-N-pyridin-3-yl-4,5′bipyrimidin-2′-amine (LAS38096), a potent and efficacious A 2B adenosine receptor antagonist. J Med Chem 50:2732-2736
18. Cristalli G, Camaioni E, Costanzi S, Vittori S, Volpini R, Klotz KN (1998) Characterization of potent ligands at human recombinant adenosine receptors. Drug Dev Res 45:176-181
19. Camaioni E, Costanzi S, Vittori S, Volpini R, Klotz KN, Cristalli G (1998) New substituted 9-alkylpurines as adenosine receptor ligands. Bioorg Med Chem 6:523-533
20. Klotz KN, Kachler S, Lambertucci C, Vittori S, Volpini R, Cristalli G (2003) 9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities. Naunyn Schmiedeberg's Arch Pharmacol 367:629-634
21. 2B adenosine receptors. Curr Top Med Chem 3:427-443
22. Volpini R, Costanzi S, Lambertucci C, Vittori S, Martini C, Trincavelli ML, Klotz K-N, Cristalli G (2005) 2- And 8-alkynyl-9-ethyladenines: synthesis and biological activity at human and rat adenosine receptors. Purinergic Signalling 1:173-181
23. Zhang L, Fan J, Vu K, Hong K, Le Brazidec JY, Shi J, Biamonte M, Busch DJ, Lough RE, Grecko R, Ran Y, Sensintaffar JL, Camal A, Lundgren K, Burrows FJ, Mansfield R, Timony GA, Ulm EH, Kasibhatla SR, Boehm M (2006) 7′-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors. J Med Chem 49:5352-5362
24. Maruyama T, Kozai S, Sasaki F (1998) Methods for the synthesis of uric acid derivatives. Nucleosides Nucleotides Nucleic Acids 19:1193-1203
25. Karaneswsky C, Thomson D, Michellys A, Ruppar P, Chen JH (2005) Preparation of benzoic acid phenylacetic derivatives as HNT-4° modulators. PCT Int. Appl. WO2005009104200-40716
26. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn Schmiedeberg's Arch Pharmacol 357:1-9
27. 3 adenosine receptor agonists. J Med Chem 41:3174-3185
28. Volpini R, Camaioni E, Costanzi S, Vittori S, Klotz K-N, Cristalli G (1999) Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes. Nucleosides Nucleotides 18:2511-2520
29. 2B ligands. J Med Chem 45:3271-3279
30. 2A receptor agonists. Curr Top Med Chem 3:387-401
31. 3 adenosine receptor. J Med Chem 50:1222-1230
32. 2A receptor agonists. Chem Med Chem 2:260-281
33. De Lean A, Hancock AA, Lefkowitz RJ (1982) Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 21:5-16
34. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108